These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3400272)

  • 21. Generation of free radicals during the reductive metabolism of the nitroaromatic compound, nilutamide.
    Berson A; Wolf C; Berger V; Fau D; Chachaty C; Fromenty B; Pessayre D
    J Pharmacol Exp Ther; 1991 May; 257(2):714-9. PubMed ID: 1851835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic and pulmonary microsomal metabolism of naphthalene to glutathione adducts: factors affecting the relative rates of conjugate formation.
    Buckpitt AR; Bahnson LS; Franklin RB
    J Pharmacol Exp Ther; 1984 Nov; 231(2):291-300. PubMed ID: 6491983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolism-dependent covalent binding of (S)-[5-3H]nicotine to liver and lung microsomal macromolecules.
    Shigenaga MK; Trevor AJ; Castagnoli N
    Drug Metab Dispos; 1988; 16(3):397-402. PubMed ID: 2900731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism of bromobenzene to glutathione adducts in lung slices from mice treated with pneumotoxicants.
    Fakjian N; Buckpitt AR
    Biochem Pharmacol; 1984 May; 33(9):1479-86. PubMed ID: 6732865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diffusion of reactive metabolites out of hepatocytes: studies with bromobenzene.
    Monks TJ; Lau SS; Gillette JR
    J Pharmacol Exp Ther; 1984 Feb; 228(2):393-9. PubMed ID: 6694117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein-reactive metabolites of carbamazepine in mouse liver microsomes.
    Lillibridge JH; Amore BM; Slattery JT; Kalhorn TF; Nelson SD; Finnell RH; Bennett GD
    Drug Metab Dispos; 1996 May; 24(5):509-14. PubMed ID: 8723729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioactivation of 8-methoxypsoralen and irreversible inactivation of cytochrome P-450 in mouse liver microsomes: modification by monoclonal antibodies, inhibition of drug metabolism and distribution of covalent adducts.
    Mays DC; Hilliard JB; Wong DD; Chambers MA; Park SS; Gelboin HV; Gerber N
    J Pharmacol Exp Ther; 1990 Aug; 254(2):720-31. PubMed ID: 2117068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formation of nontoxic reactive metabolites of p-bromophenol. Identification of a new glutathione conjugate.
    Monks TJ; Lau SS; Highet RJ
    Drug Metab Dispos; 1984; 12(4):432-7. PubMed ID: 6148209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for hepatic formation, export and covalent binding of reactive naphthalene metabolites in extrahepatic tissues in vivo.
    Buckpitt AR; Warren DL
    J Pharmacol Exp Ther; 1983 Apr; 225(1):8-16. PubMed ID: 6834280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro studies on the metabolic activation of the furanopyridine L-754,394, a highly potent and selective mechanism-based inhibitor of cytochrome P450 3A4.
    Sahali-Sahly Y; Balani SK; Lin JH; Baillie TA
    Chem Res Toxicol; 1996 Sep; 9(6):1007-12. PubMed ID: 8870989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative studies of the in vitro metabolism and covalent binding of 14C-benzene by liver slices and microsomal fraction of mouse, rat, and human.
    Brodfuehrer JI; Chapman DE; Wilke TJ; Powis G
    Drug Metab Dispos; 1990; 18(1):20-7. PubMed ID: 1970773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450.
    Marinello AJ; Bansal SK; Paul B; Koser PL; Love J; Struck RF; Gurtoo HL
    Cancer Res; 1984 Oct; 44(10):4615-21. PubMed ID: 6380709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism and covalent binding of [14C]toluene by human and rat liver microsomal fractions and liver slices.
    Chapman DE; Moore TJ; Michener SR; Powis G
    Drug Metab Dispos; 1990; 18(6):929-36. PubMed ID: 1981539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism of trichloroethylene in isolated hepatocytes, microsomes, and reconstituted enzyme systems containing cytochrome P-450.
    Miller RE; Guengerich FP
    Cancer Res; 1983 Mar; 43(3):1145-52. PubMed ID: 6825087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monooxygenase-mediated activation of chlorotrianisene (TACE) in covalent binding to rat hepatic microsomal proteins.
    Juedes MJ; Bulger WH; Kupfer D
    Drug Metab Dispos; 1987; 15(6):786-93. PubMed ID: 2893703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of phenolic metabolites in the irreversible protein-binding of 14C-bromobenzene catalysed by rat liver microsomes.
    Hesse S; Wolff T; Mezger M
    Arch Toxicol Suppl; 1980; 4():358-62. PubMed ID: 6933937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bromobenzene metabolism in isolated rat hepatocytes. 18O2 incorporation studies.
    Dankovic D; Billings RE; Seifert W; Stillwell WG
    Mol Pharmacol; 1985 Feb; 27(2):287-95. PubMed ID: 3969072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The covalent binding of bromobenzene with nucleic acids.
    Colacci A; Arfellini G; Mazzullo M; Prodi G; Grilli S
    Toxicol Pathol; 1985; 13(4):276-82. PubMed ID: 2422722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of adducts of bromobenzene 3,4-oxide with rat liver microsomal protein sulfhydryl groups using specific antibodies.
    Rombach EM; Hanzlik RP
    Chem Res Toxicol; 1999 Feb; 12(2):159-63. PubMed ID: 10027793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A proteomic analysis of bromobenzene reactive metabolite targets in rat liver cytosol in vivo.
    Koen YM; Gogichaeva NV; Alterman MA; Hanzlik RP
    Chem Res Toxicol; 2007 Mar; 20(3):511-9. PubMed ID: 17305373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.